{"date":"2025-08-28","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2025-08-28-2338-1ixue48","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-08-28","time":"23:38:03","subject":"(補充公告)110/12/28本公司暨重要子公司Alvogen Korea取得Alvogen Pharma Limited特別股股權之公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-08-28 23:38，「(補充公告)110/12/28本公司暨重要子公司Alvogen Korea取得Alvogen Pharma Limite」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-08-28-1927-1b1roin","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-08-28","time":"19:27:11","subject":"本公司基於研發效益考量，決定終止研發中新藥OB318開發","clause":"第10款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-08-28 19:27，「本公司基於研發效益考量，決定終止研發中新藥OB318開發」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2025-08-28-1858-1m275t5","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-08-28","time":"18:58:47","subject":"公告本公司114年股東常會通過解除董事長競業禁止之限制案","clause":"第21款","fact_date":"2025-06-25","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-08-28 18:58，「公告本公司114年股東常會通過解除董事長競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-28-1814-ecant0","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-28","time":"18:14:32","subject":"本公司114年9月9日受邀參加第一金證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-28 18:14，「本公司114年9月9日受邀參加第一金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-08-28-1801-17u9v5u","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-08-28","time":"18:01:14","subject":"更正本公司114/08/08依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第二十二條第一項第三款規定之公告","clause":"第23款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-08-28 18:01，「更正本公司114/08/08依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第二十二條第一項第三款規定之」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-08-28-1739-1h6g9br","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-08-28","time":"17:39:46","subject":"更正公告本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-08-28 17:39，「更正公告本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4116-2025-08-28-1720-1df7q76","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2025-08-28","time":"17:20:49","subject":"公告本公司處分不動產","clause":"第20款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2025-08-28 17:20，「公告本公司處分不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2025-08-28-1608-1pzjlpi","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-28","time":"16:08:08","subject":"公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"第44款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2025-08-28 16:08，「公告本公司預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-08-28-1406-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-08-28","time":"14:06:15","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-08-28 14:06，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-08-28-1405-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-08-28","time":"14:05:49","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2025-08-28","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-08-28 14:05，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}